DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 119 filers reported holding DENALI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $772 | -99.7% | 37,404 | +439.0% | 0.07% | +120.0% |
| Q1 2022 | $223,000 | -14.2% | 6,940 | +19.0% | 0.03% | -9.1% |
| Q4 2021 | $260,000 | -65.4% | 5,834 | -60.8% | 0.03% | -57.1% |
| Q3 2021 | $751,000 | +135.4% | 14,892 | +166.7% | 0.08% | +45.3% |
| Q1 2021 | $319,000 | -39.9% | 5,583 | -78.2% | 0.05% | -10.2% |
| Q2 2019 | $531,000 | +145.8% | 25,564 | +174.3% | 0.06% | +168.2% |
| Q1 2019 | $216,000 | – | 9,320 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |